BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 28757612)

  • 1. The CD24-Siglec G axis protects mice against cuprizone-induced oligodendrocyte loss: targeting danger signal for neuroprotection.
    Li N; Zheng P; Liu Y
    Cell Mol Immunol; 2018 Jan; 15(1):79-81. PubMed ID: 28757612
    [No Abstract]   [Full Text] [Related]  

  • 2. CD24-Siglec axis is an innate immune checkpoint against metaflammation and metabolic disorder.
    Wang X; Liu M; Zhang J; Brown NK; Zhang P; Zhang Y; Liu H; Du X; Wu W; Devenport M; Tao W; Mao-Draayer Y; Chen GY; Chen YE; Zheng P; Liu Y
    Cell Metab; 2022 Aug; 34(8):1088-1103.e6. PubMed ID: 35921817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD24 and Siglec-10 selectively repress tissue damage-induced immune responses.
    Chen GY; Tang J; Zheng P; Liu Y
    Science; 2009 Mar; 323(5922):1722-5. PubMed ID: 19264983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Siglec-G/10 in self-nonself discrimination of innate and adaptive immunity.
    Chen GY; Brown NK; Zheng P; Liu Y
    Glycobiology; 2014 Sep; 24(9):800-6. PubMed ID: 24996822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Siglec-G-CD24 axis controls the severity of graft-versus-host disease in mice.
    Toubai T; Hou G; Mathewson N; Liu C; Wang Y; Oravecz-Wilson K; Cummings E; Rossi C; Evers R; Sun Y; Wu J; Choi SW; Fang D; Zheng P; Liu Y; Reddy P
    Blood; 2014 May; 123(22):3512-23. PubMed ID: 24695850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GATA3 Encapsulated by Tumor-Associated Macrophage-Derived Extracellular Vesicles Promotes Immune Escape and Chemotherapy Resistance of Ovarian Cancer Cells by Upregulating the CD24/Siglec-10 Axis.
    Chen C; Zhang L; Ruan Z
    Mol Pharm; 2023 Feb; 20(2):971-986. PubMed ID: 36547230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD24-Siglec G/10 discriminates danger- from pathogen-associated molecular patterns.
    Liu Y; Chen GY; Zheng P
    Trends Immunol; 2009 Dec; 30(12):557-61. PubMed ID: 19786366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Siglec-G signaling DAMPens GVHD.
    Zeiser R
    Blood; 2014 May; 123(22):3376-7. PubMed ID: 24876528
    [No Abstract]   [Full Text] [Related]  

  • 9. The biological roles of CD24 in ovarian cancer: old story, but new tales.
    Gu Y; Zhou G; Tang X; Shen F; Ding J; Hua K
    Front Immunol; 2023; 14():1183285. PubMed ID: 37359556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role of Siglec-G on Immune Cells in Sepsis.
    Royster W; Wang P; Aziz M
    Front Immunol; 2021; 12():621627. PubMed ID: 33708213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting CD24/Siglec-10 signal pathway for cancer immunotherapy: recent advances and future directions.
    Li X; Tian W; Jiang Z; Song Y; Leng X; Yu J
    Cancer Immunol Immunother; 2024 Jan; 73(2):31. PubMed ID: 38279998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nano-LYTACs for Degradation of Membrane Proteins and Inhibition of CD24/Siglec-10 Signaling Pathway.
    Wang K; Yu A; Liu K; Feng C; Hou Y; Chen J; Ma S; Huang L; Dai X
    Adv Sci (Weinh); 2023 May; 10(13):e2300288. PubMed ID: 36866919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amelioration of sepsis by inhibiting sialidase-mediated disruption of the CD24-SiglecG interaction.
    Chen GY; Chen X; King S; Cavassani KA; Cheng J; Zheng X; Cao H; Yu H; Qu J; Fang D; Wu W; Bai XF; Liu JQ; Woodiga SA; Chen C; Sun L; Hogaboam CM; Kunkel SL; Zheng P; Liu Y
    Nat Biotechnol; 2011 May; 29(5):428-35. PubMed ID: 21478876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel insights into the function of CD24: A driving force in cancer.
    Altevogt P; Sammar M; Hüser L; Kristiansen G
    Int J Cancer; 2021 Feb; 148(3):546-559. PubMed ID: 32790899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leishmania donovani Utilize Sialic Acids for Binding and Phagocytosis in the Macrophages through Selective Utilization of Siglecs and Impair the Innate Immune Arm.
    Roy S; Mandal C
    PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004904. PubMed ID: 27494323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multivalent Interactions of Human Primary Amine Oxidase with the V and C22 Domains of Sialic Acid-Binding Immunoglobulin-Like Lectin-9 Regulate Its Binding and Amine Oxidase Activity.
    Elovaara H; Parkash V; Fair-Mäkelä R; Salo-Ahen OM; Guédez G; Bligt-Lindén E; Grönholm J; Jalkanen S; Salminen TA
    PLoS One; 2016; 11(11):e0166935. PubMed ID: 27893774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensing the neuronal glycocalyx by glial sialic acid binding immunoglobulin-like lectins.
    Linnartz-Gerlach B; Mathews M; Neumann H
    Neuroscience; 2014 Sep; 275():113-24. PubMed ID: 24924144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Siglecs: A journey through the evolution of sialic acid-binding immunoglobulin-type lectins.
    Bornhöfft KF; Goldammer T; Rebl A; Galuska SP
    Dev Comp Immunol; 2018 Sep; 86():219-231. PubMed ID: 29751010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD24-Siglec interactions in inflammatory diseases.
    Liu Y; Zheng P
    Front Immunol; 2023; 14():1174789. PubMed ID: 37228622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Siglec-7 expression is reduced on a natural killer (NK) cell subset of obese humans.
    Rosenstock P; Horstkorte R; Gnanapragassam VS; Harth J; Kielstein H
    Immunol Res; 2017 Oct; 65(5):1017-1024. PubMed ID: 28786023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.